AI News

Cambricon and other STAR Market leaders disclose earnings: AI industry chain boom is translating into profits

East MoneyUpdated Nov 16 19:52

AI summary

Five AI industry chain companies on the STAR Market—Cambricon, Biwin Storage, Shengyi Electronics, Yuanjie Technology, and Lianxun Instruments—have collectively disclosed operating data, as AI computing demand is translating into actual revenue and profits. Cambricon's revenue for the first three quarters of 2026 was 9.526 billion yuan, up 106.76% year on year, with net profit attributable to shareholders of 3.715 billion yuan, up 131.49% year on year; Yuanjie Technology's third-quarter revenue is expected to grow 264.56% to 292.60% year on year. Shengyi Electronics expects net profit attributable to shareholders for the first three quarters to grow 68% to 75% year on year, while Lianxun Instruments expects growth of 1866.00% to 2072.95%.

Body · AI translation

Main text

Amid market attention on short-term volatility in the technology sector, several leading companies on the STAR Market have responded to market concerns through announcements.

Recently, seven companies—Cambricon, Biwin Storage, Shengyi Electronics, Yuanjie Technology, Lianxun Instruments, RemeGen, and APT Medical—disclosed their recent production and operating conditions in a concentrated manner. From AI computing power chips, storage, and high-speed interconnect to innovative drugs and interventional medical devices, these companies have demonstrated the resilience of the STAR Market's fundamentals through performance growth, order reserves, R&D investment, and capacity building.

A reporter from the STAR Market Daily noted that, more importantly, the relevant companies have continued to achieve key technological breakthroughs, pushing domestic substitution in key industrial chains to greater depth. Technological self-reliance and self-strengthening are being translated into verifiable industrial progress and operating results, injecting stability into market expectations.

Among the seven STAR Market companies that made the above statements, five come from different segments of the artificial intelligence industrial chain.

As can be seen from the relevant announcements, the prosperity signals of the industrial chain are not merely at the expectation level: chip companies are seeing rapid revenue and profit growth, PCB, optical chip, and test equipment companies maintain sound order momentum, the demand structure for storage products is accelerating its upgrade, and capacity building and next-generation product validation are also advancing in parallel. Demand across the industrial chain driven by computing power capital expenditure is gradually being translated into the operating results of listed companies.

As a computing power chip company, Cambricon stated that demand in the artificial intelligence computing power market remains robust and can support the company's steady business growth. In the first three quarters of 2026, the company achieved operating revenue of 9.526 billion yuan, up 106.76% year on year; net profit attributable to shareholders of the parent company was 3.715 billion yuan, up 131.49% year on year, and up 80.38% from the full year of 2025. At the same time, the company's R&D investment in the first three quarters was 1.225 billion yuan, up 45.35% year on year.

According to statistics compiled by a reporter from the STAR Market Daily, Cambricon's single-quarter net profit once again hit a new high since its listing.

In Cambricon's view, as large-model technology continues to evolve, the market not only needs more efficient computing hardware to reduce training and inference costs, but also needs more complete software platforms to improve the ease of use, scalability, compatibility, and stability of chips in complex scenarios. The company will continue to maintain high-intensity R&D investment in key directions such as chip platforms and software platforms for large models, and strengthen its software-hardware collaborative optimization capabilities.

The growth in computing power demand is also driving the upgrading of the storage industry. Biwin Storage stated that since 2026, affected by factors such as the continued advancement of artificial intelligence computing infrastructure construction and the growth in storage demand from global data centers and cloud service providers, prices of major storage products such as DRAM and NAND Flash have risen significantly, and industry prosperity has improved. The company is actively expanding application markets such as emerging AI edge devices, PC and enterprise-level storage, and smart vehicles, and continues to advance its "storage + wafer-level advanced packaging and testing" dual-wheel-driven strategy, pursuing technology R&D and industrial application in areas such as advanced storage, storage-computing integrated packaging, and high-speed optoelectronic interconnect.

The PCB segment is likewise feeling the demand upturn. Shengyi Electronics stated that the company currently has ample orders, a stable supply chain, and a relatively high capacity utilization rate. Thanks to the high prosperity of downstream demand in areas such as AI computing power and high-speed communications, the company expects net profit attributable to shareholders of the parent company for the first three quarters of 2026 to be 1.8686 billion yuan to 1.9517 billion yuan, up 68% to 75% year on year.

Shengyi Electronics believes that, as AI servers and high-speed switches accelerate their upgrading, high-speed, high-layer-count PCBs have become key components for ensuring high-speed signal integrity and supporting the stable release of computing power. Orders for the company's data center-related products such as AI servers and 800G and 1.6T switches are growing steadily, and its 1.6T optical module products have achieved breakthrough progress.

▍Capacity in the optical communications field is being released at an accelerated pace, with technology R&D remaining at a high level

In the high-speed optical communications field, Yuanjie Technology and Lianxun Instruments disclosed their latest operating progress from the laser chip and test instrument segments, respectively.

Yuanjie Technology expects to achieve operating revenue of 650 million yuan to 700 million yuan in the third quarter of 2026, up 264.56% to 292.60% year on year; it expects net profit attributable to shareholders of the parent company of 403 million yuan to 453 million yuan, up 578.85% to 659.70% year on year.

In terms of technology and capacity, Yuanjie Technology's multiple products for new packaging technologies such as CPO and NPO are steadily advancing in line with customer demand, and R&D investment in EML and CW products remains at a high level. The civil engineering, part of the cleanrooms, and supporting facilities of the second phase of its optoelectronic communications semiconductor chip and device R&D and production base have been completed, the first batch of production equipment is expected to enter the plant soon, and the project is expected to begin forming capacity between the end of 2026 and early 2027.

Lianxun Instruments stated that downstream customer demand is robust and its order reserves on hand are relatively ample. Core test instruments such as sampling oscilloscopes, bit error rate analyzers, and clock recovery units for 800G and 1.6T high-speed optical module testing are the company's main products to be delivered in 2026. The company expects net profit attributable to shareholders of the parent company for the first three quarters of 2026 to be 1.9 billion yuan to 2.1 billion yuan, up 1,866.00% to 2,072.95% year on year.

For next-generation speeds, Lianxun Instruments' new-generation sampling oscilloscopes and supporting clock recovery units can meet the eye diagram testing requirements of 2.4T and 3.2T, and the relevant self-developed sample-and-hold chips have been successfully taped out and are planned to be sent to leading industry users for sample validation.

▍Development momentum in innovative drugs and medical devices continues to be released

The vitality of technological innovation is also reflected in the biopharmaceutical and high-end medical device fields.

RemeGen stated that the commercialization of its core products is advancing steadily and overall operating quality continues to improve. In the first half of 2026, the company achieved operating revenue of 5.853 billion yuan, up 433.11% year on year; net profit attributable to shareholders was 4.662 billion yuan, turning from loss to profit year on year; net cash flow from operating activities was 4.214 billion yuan, further enhancing profit quality and operational resilience.

In terms of internationalization, RemeGen has facilitated global licensing of four core drugs—telitacicept, disitamab vedotin, RC28, and RC148—with cumulative total transaction value exceeding US$12.6 billion. The company stated that it will continue to focus on core therapeutic areas such as autoimmune diseases and oncology, and advance clinical research, commercialization, and global cooperation.

Apt Medical, meanwhile, is optimistic about the long-term demand for minimally invasive interventional medical devices. The company stated that its current production and operating conditions are good, product market coverage has further improved, and R&D capabilities have continued to strengthen. From 2021 to 2025, the company's operating revenue grew from 829 million yuan to 2.584 billion yuan, with a compound annual growth rate of 32.88%; net profit attributable to shareholders grew from 208 million yuan to 821 million yuan, with a compound annual growth rate of 40.95%. In the first half of 2026, the company's operating revenue and net profit attributable to shareholders increased by 25.75% and 26.38% year on year, respectively; the growth rates of operating revenue and net profit in the first three quarters increased compared with the first half of the year.

Looking ahead, Apt Medical will continue to increase the coverage rate and hospital penetration rate of vascular interventional products, accelerate the market access of pulsed ablation consumables, and promote the accelerated international market layout of three-dimensional electrophysiology systems, pulsed electric field ablation solutions, and peripheral products. The company will also continue to advance digital and intelligent upgrades and strengthen technological innovation and commercialization of results in fields such as electrophysiology and vascular intervention.

▍Conveying confidence through operating performance and shareholder returns

The Science and Technology Innovation Board Daily reporter also noted that, in addition to disclosing industry trends and business progress, the relevant companies also responded to investor concerns through dividends, share buybacks, and other methods.

Biwin Storage has completed the distribution of equity for the 2025 annual and 2026 semi-annual periods since the beginning of 2026, with cumulative cash dividends of approximately 300 million yuan; the company also completed a share buyback of approximately 250 million yuan on October 19, with all relevant shares used for cancellation and reduction of registered capital. Its controlling shareholder, actual controller, and chairman Sun Chengsi recently again proposed a buyback of company shares of 200 million yuan to 250 million yuan for cancellation.

Shengyi Electronics' 2025 annual and semi-annual cash dividends totaled 741 million yuan, accounting for 50.29% of the net profit attributable to shareholders for the year; since its listing in 2021, the company has paid cumulative cash dividends of 1.486 billion yuan. The company also recently launched a share buyback plan of 100 million yuan to 200 million yuan.

Apt Medical has implemented four rounds of buybacks since its listing, with buyback amounts exceeding 600 million yuan; it implemented cash dividends for six consecutive years from 2020 to 2025, with cumulative cash dividends of 653 million yuan.

(Source: Cailian Press) Mid-body of the article Embedded advertisement

Source

East Money